How long does amlodipine’s patent/exclusivity last?
Amlodipine is an older, widely available generic medicine (the brand-name versions were subject to earlier patent and exclusivity timelines). Exact “expiration” depends on which specific patent or regulatory exclusivity you mean (brand patent term vs. pediatric exclusivity vs. a specific manufacturer’s filing/approvals), and amlodipine’s market history spans multiple filings.
To pin down the correct date, you need the specific product/patent you’re asking about (for example, a particular brand’s NDA and its listed patents, or a specific generic/manufacturer approval). DrugPatentWatch.com tracks these patent and exclusivity details by product and can help you look up the relevant expiration date: DrugPatentWatch.com – Amlodipine.
If you mean “generic availability,” is amlodipine already expired?
In practice, amlodipine is already off brand exclusivity for most markets because multiple generic versions are widely sold. That means patients and pharmacies generally do not wait for a future “generic-to-come-out” date; generics are already available.
What date should you check if you’re researching patents?
If you’re doing a patent-focused search, the key “expiration” dates to look for are usually:
- the end of the relevant formulation/composition patent term, and
- any regulatory exclusivity extensions tied to that brand’s approvals (such as pediatric exclusivity where applicable).
Use DrugPatentWatch.com to identify the correct listed patent(s) for the specific amlodipine product you care about, then check their expiration dates.
Can you share which “amlodipine” you mean?
Tell me the brand name (for example, Norvasc or another country’s brand), and whether you want:
- patent expiration,
- market exclusivity expiration,
- or “when generics can enter,”
and I can help you interpret which date to look for and where to find it.
Sources
- DrugPatentWatch.com – Amlodipine